Evidence map›Paper›PMID 28327575›Full record

ArticleEuropean journal of human genetics : EJHG2017

Analysis of exome data for 4293 trios suggests GPI-anchor biogenesis defects are a rare cause of developmental disorders.

Alistair T Pagnamenta, Yoshiko Murakami, John M Taylor, Consuelo Anzilotti, Malcolm F Howard, Venessa Miller, Diana S Johnson, Shereen Tadros, Sahar Mansour, I Karen Temple and 9 more

Open access · hybridAbstract read
In one paragraph

Article in European journal of human genetics : EJHG, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 1 pooled it
7.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 1 synthesis or guideline pooled it, 76 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. A Novel Homozygous Missense Variant ofInternational journal of molecular sciences · 2025
    Article
  5. Article
  6. Observational
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. New Insights Relating Gasdermin B to the Onset of Childhood Asthma.American journal of respiratory cell and molecular biology · 2022
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 6 institutions in 2 countries.

Alistair T PagnamentaNational Institute for Health Research Oxford Biomedical Research Centre, Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK.
Yoshiko MurakamiDepartment of Immunoregulation, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.
John M TaylorOxford NHS Regional Molecular Genetics Laboratory, Oxford University Hospitals NHS Trust, Oxford, UK.
Consuelo AnzilottiThe Henry Wellcome Building for Molecular Physiology, University of Oxford, Oxford, UK.
Malcolm F HowardNational Institute for Health Research Oxford Biomedical Research Centre, Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK.
Venessa MillerDepartment of Clinical Genetics, Oxford University Hospitals NHS Trust, Oxford, UK.
Diana S JohnsonSheffield Children's Hospital, Western Bank, Sheffield, UK.
Shereen TadrosSouth West Thames Regional Genetics Service, St George's Healthcare NHS Foundation Trust, London, UK.
Sahar MansourSouth West Thames Regional Genetics Service, St George's Healthcare NHS Foundation Trust, London, UK.
I Karen TempleHuman Genetics and Genomic Medicine, Faculty of Medicine, University of Southampton and Wessex Clinical Genetics Service, University Hospital NHS Trust, Princess Anne Hospital, Southampton, UK.
Rachel FirthHuman Genetics and Genomic Medicine, Faculty of Medicine, University of Southampton and Wessex Clinical Genetics Service, University Hospital NHS Trust, Princess Anne Hospital, Southampton, UK.
Elisabeth RosserDepartment of Clinical Genetics, Great Ormond Street Hospital for Children NHS Trust, London, UK.
Rachel E HarrisonDepartment of Clinical Genetics, Nottingham University Hospitals NHS Trust, Nottingham, UK.
Bronwen KerrManchester Centre for Genomic Medicine, Institute of Human Development, Faculty of Medical and Human Sciences, University of Manchester, Manchester, UK.
Niko PopitschNational Institute for Health Research Oxford Biomedical Research Centre, Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK.
DDD Study
Taroh KinoshitaDepartment of Immunoregulation, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.
Jenny C TaylorNational Institute for Health Research Oxford Biomedical Research Centre, Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK.
Usha KiniDepartment of Clinical Genetics, Oxford University Hospitals NHS Trust, Oxford, UK.
Centre for Human Genetics · GBOxford University Hospitals NHS Trust · GBNottingham University Hospitals NHS Trust · GBPrincess Anne Hospital · GBSouth West London and St George's Mental Health NHS Trust · GBGreat Ormond Street Hospital · GB

Funding

Department of HealthWellcome TrustWellcome Trust 090532/Z/09/ZWellcome Trust WT098051
6 · The paper itself

Abstract

Over 150 different proteins attach to the plasma membrane using glycosylphosphatidylinositol (GPI) anchors. Mutations in 18 genes that encode components of GPI-anchor biogenesis result in a phenotypic spectrum that includes learning disability, epilepsy, microcephaly, congenital malformations and mild dysmorphic features. To determine the incidence of GPI-anchor defects, we analysed the exome data from 4293 parent-child trios recruited to the Deciphering Developmental Disorders (DDD) study. All probands recruited had a neurodevelopmental disorder. We searched for variants in 31 genes linked to GPI-anchor biogenesis and detected rare biallelic variants in PGAP3, PIGN, PIGT (n=2), PIGO and PIGL, providing a likely diagnosis for six families. In five families, the variants were in a compound heterozygous configuration while in a consanguineous Afghani kindred, a homozygous c.709G>C; p.(E237Q) variant in PIGT was identified within 10-12 Mb of autozygosity. Validation and segregation analysis was performed using Sanger sequencing. Across the six families, five siblings were available for testing and in all cases variants co-segregated consistent with them being causative. In four families, abnormal alkaline phosphatase results were observed in the direction expected. FACS analysis of knockout HEK293 cells that had been transfected with wild-type or mutant cDNA constructs demonstrated that the variants in PIGN, PIGT and PIGO all led to reduced activity. Splicing assays, performed using leucocyte RNA, showed that a c.336-2A>G variant in PIGL resulted in exon skipping and p.D113fs*2. Our results strengthen recently reported disease associations, suggest that defective GPI-anchor biogenesis may explain ~0.15% of individuals with developmental disorders and highlight the benefits of data sharing.

Indexed as

ExomePolymorphism, Single NucleotideAcyltransferasesAdultCarboxylic Ester HydrolasesChildDevelopmental DisabilitiesHEK293 CellsHeterozygoteHomozygoteHumansMembrane ProteinsN-AcetylglucosaminyltransferasesPedigreePhosphotransferasesReceptors, Cell SurfaceAcyltransferasesCarboxylic Ester HydrolasesCOOH-terminal signal transamidaseMembrane ProteinsN-AcetylglucosaminyltransferasesPGAP3 protein, humanPhosphotransferasesPIGL protein, humanPIGN protein, humanPIGO protein, humanReceptors, Cell Surface

Identifiers

PMID28327575
PMCPMC5477361
OpenAlexW2603634354

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.